MeSH D008593 - menopause
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Allergan | Estropipate | Estropipate | 1993-09-23 | |||
| Barr Pharmaceuticals | Estropipate | Estropipate | 1996-11-27 | |||
| Duchesnay | Ospemifene | Osphena | 2022-11-02 | 2013-02-26 | ||
| Duramed Pharmaceuticals | Estropipate | Estropipate | 1999-11-01 | |||
| Mylan | Estropipate | Estropipate | 1999-08-26 | |||
| Pfizer | Bazedoxifene | Conbriza | 2009-04-17 | |||
| Bazedoxifene, Oestrogens conjugated | Duavive | 2014-12-16 | ||||
| Estropipate | Ogen | 1982-01-01 | ||||
| Pharmacia & Upjohn | Estropipate | Ogen | 1982-01-01 | |||
| Shionogi | Ospemifene | Senshio | 2015-01-14 | |||
| Sun Pharmaceutical Industries | Estropipate | Ortho-est | 1991-02-27 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
77%10/13
Phase 2
65%13/20
Phase 3
43%12/28
Approved: 3Overall Success rate: 21%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use